Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Modeling SARS-CoV-2 in mice: Among the research tools necessary to develop medical interventions to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, high on the list are informative animal models with which to study viral pathogenesis. Gu et al. developed a mouse model in which a SARS-CoV-2 strain was infectious and could cause an inflammatory response and moderate pneumonia. Adaptation of this viral strain in the mouse appeared to be dependent on a critical amino acid change, Asn 501 to Tyr (N501Y), within the receptor-binding domain of the viral spike protein. The new mouse model was used to study neutralizing antibodies and a vaccine candidate against the virus. Science , this issue p. 1603
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although mouse models have the most information available about their biology and many research tools, the ACE2 receptor is significantly different between mice and humans; so mouse models most often use a humanized ACE2 or lung passage to overcome this obstacle. 177-179”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [179]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Self-citationA novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Self-citationA pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Self-citationDipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
Raj, V. S., Mou, H., Smits, S. L., Dekkers, D. H. W., Müller, M. A., Dijkman, R., Muth, D., Demmers, J. A. A., Zaki, A., Fouchier, R. A. M., et al. (2013) · Nature · doi:10.1038/nature12005 · Cited by 2,061
Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2
Shi, J., Wen, Z., Zhong, G., Yang, H., Wang, C., Huang, B., Liu, R., He, X., Shuai, L., Sun, Z., et al. (2020) · Science · doi:10.1126/science.abb7015 · Cited by 1,911
The spike protein of SARS-CoV — a target for vaccine and therapeutic development
Du, L., He, Y., Zhou, Y., Liu, S., Zheng, B.-J., & Jiang, S. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2090 · Cited by 1,661
Self-citationTai, W., He, L., Zhang, X., Pu, J., Voronin, D., Jiang, S., Zhou, Y., & Du, L. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0400-4 · Cited by 1,654
Self-citationImmunology of COVID-19: Current State of the Science
Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623
Self-citationDevelopment of an inactivated vaccine candidate for SARS-CoV-2
Gao, Q., Bao, L., Mao, H., Wang, L., Xu, K., Yang, M., Li, Y., Zhu, L., Wang, N., Lv, Z., et al. (2020) · Science · doi:10.1126/science.abc1932 · Cited by 1,434
Self-citationCarsana, L., Sonzogni, A., Nasr, A., Rossi, R. S., Pellegrinelli, A., Zerbi, P., Rech, R., Colombo, R., Antinori, S., Corbellino, M., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30434-5 · Cited by 1,396
Cited by
Items 701–786 of 786
Caliari, V. D. A., Muniz, D. D. M., Cavalcanti, J. V. C., Saraiva, P. R. B. D. C., Arruda, A. T. C., Melo, J. V. A. S. N. D., Arruda, A. G. T. C., & Neto, J. R. D. E. (2022) · Latin American Publicações eBooks · doi:10.47174/lap2020.ed.00000108
CARACTERÍSTICAS CLÍNICAS DA COVID-19
da Rosa, M. M., Pereira, M. C., Pessoa-e-Silva, R., Sá, J. L. F., Silva, R. C., Mendonça, A. C. S., Lima, C. A. D. O., Ferreira, M. D. A., Rego, M. J. B. M., & Pitta, M. G. D. R. (2022) · Latin American Publicações eBooks · doi:10.47174/lap2020.ed.0000095
mRNA-1273 and Ad26.COV2.S Vaccines Protect Against the B.1.621 Variant of SARS-CoV-2Preprint
Darling, T. L., Ying, B., Whitener, B. M., VanBlargan, L. A., Bricker, T. L., Liang, C.-Y., Joshi, A., Bamunuarachchi, G., Seehra, K., Schmitz, A. J., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4001952
Are the emerging SARS-COV-2 mutations friend or foe?Preprint
Erol, A. (2020) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/zgmk4
López-Cortés, G. I., Palacios-Pérez, M., Zamudio, G. S., Veledíaz, H. F., Ortega, E., & José, M. V. (2021) · Research Square · doi:10.21203/rs.3.rs-453111/v1
An Engineering Model of the COVID-19 Trajectory to Predict Success of Isolation InitiativesPreprint
King, S., & Striolo, A. (2020) · doi:10.14324/111.444/000029.v2
Shipovalov, A. V., Kudrov, G. A., Старчевская, М., & Пьянков, О. (2022) · doi:10.21055/preprints-3112090
Tuncel, G., Ergören, M. Ç., Baddal, B., Tulay, P., Özverel, C. S., Güler, E., Süer, H. K., Sayan, M., & Şanlıdağ, T. (2022) · Future Virology · doi:10.2217/fvl-2021-0273
Demircioğlu, Ö., Kocakaya, D., Çimşit, C., Sarınoğlu, R. C., Toprak, N. Ü., & Çimşit, Ç. (2022) · Journal of Health Sciences and Medicine · doi:10.32322/jhsm.1114475
Perspective Chapter: Bioinformatics Study of the Evolution of SARS-CoV-2 Spike Protein
Podlipnik, Č., Alexandrova, R., Pleško, S., Bren, U., & Jukič, M. (2022) · Infectious diseases · doi:10.5772/intechopen.105915
Perspective Chapter: Real-Time Genomic Surveillance for SARS-CoV-2 on Center Stage
Paz, M., Moreno, P., & Moratorio, G. (2022) · Infectious diseases · doi:10.5772/intechopen.107842
SARS-CoV-2’NİN SÜREGELEN EVRİMİ: PANDEMİNİN SONUNA NE KADAR YAKINIZ?
Kilbaş, E. P. K., & Altındiş, M. (2022) · JOURNAL OF BIOTECHNOLOGY AND STRATEGIC HEALTH RESEARCH · doi:10.34084/bshr.1200144
"SARS-CoV-2 Antibodies and Immunity: Still to Explore for COVID-19"
Chakraborty, A. K. (2022) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2022.45.007229
Molozhanova, A. V., Nychyk, S. A., Hudz, N. V., & Тарасов, О. А. (2022) · Bulletin Veterinary biotechnology · doi:10.31073/vet_biotech41-08
Safeguarding Against the Analog of Antimicrobial-Resistance Development
Mueller, S. (2022) · Springer eBooks · doi:10.1007/978-3-031-18903-6_6
Brahma, N. K. (2023) · Archives of Immunology Research and Therapy · doi:10.58489/2836-5003/008
SARS-CoV-2: Structure, Pathogenesis, and Diagnosis
Goverdhan, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-87539-4.00002-6 · Cited by 2
(2023) · Engineering Open Access · doi:10.33140/eoa.01.01.04
Spike (S) Glycoprotein N501Y Mutant
Zhang, J. (2023) · Springer series in biophysics · doi:10.1007/978-3-031-36773-1_9
Alternative genome sequencing approaches of SARS-CoV-2 using Ion AmpliSeq Technology
Hasan, M. S., Rahman, M. S., Das, P. K., Alam, A. S. M. R. U., Islam, O. K., Al‐Emran, H. M., Hossain, M. A., & Jahid, I. K. (2024) · MethodsX · doi:10.1016/j.mex.2024.102646
The Evolution in Pharmacology of Infectious Diseases: 2022
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-4661-1 · Cited by 1
Qin, T., Shen, B., Li, E., Jin, S., Luo, R., Zhang, Y., Qi, J., Deng, X., Shi, Z., Wang, T., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22671341
Self-citationYi, C., Sun, X., Lin, Y., Gu, C., Ding, L., Lu, X., Yang, Z. R., Zhang, Y., Ma, L., Gu, W., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16815705
Self-citationQin, T., Shen, B., Li, E., Jin, S., Luo, R., Zhang, Y., Qi, J., Deng, X., Shi, Z., Wang, T., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22671344
Self-citationYi, C., Sun, X., Lin, Y., Gu, C., Ding, L., Lu, X., Yang, Z. R., Zhang, Y., Ma, L., Gu, W., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16815708
Self-citationYi, C., Sun, X., Lin, Y., Gu, C., Ding, L., Lu, X., Yang, Z. R., Zhang, Y., Ma, L., Gu, W., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16815702
Self-citationInfection of the human testis by emergent viruses : the case of Zika virus and SARS-CoV-2
Bourgeau, S. (2022) · theses.fr (ABES) · doi:10.70675/e77e4cd3z85b8z4454z8190z630ce4e72020
In Vitro and in Vivo Evaluation Tools of SARS-CoV-2 Antiviral Drugs
Sharma, G. K., Nehul, S., Choudhary, S., & Mahajan, S. (2024) · Livestock diseases and management · doi:10.1007/978-981-99-9195-2_11
Predicting Transmissibility-Increasing Coronavirus (SARS-CoV-2) Mutations
Çalışkan, E., Işık, M., Kuru, C. İ., & Chakraborty, S. (2024) · COVID · doi:10.3390/covid4060055
Differential epitope prediction across diverse circulating variants of SARS-COV-2 in Brazil
Cavalcanti-Dantas, V. D. M., Fernandes, B., Dantas, P. H. L. F., Uchoa, G. R., Mendes, A. F., Júnior, W. O. D. A., Castellano, L. R. C., Fernandes, A. I. V., Goulart, L. R., Oliveira, R. A. D. S., et al. (2024) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2024.108139
Eosinophils protect against SARS-CoV-2 following a vaccine breakthrough infectionPreprint
Moore, K. M., Foster, S. L., Kar, M., Floyd, K. A., Elrod, E. J., Williams, M. E., Velden, J. W. V., Ellis, M. L., Malik, A. A., Wali, B., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.08.607190
Vaccine Research and Development in India for COVID-19 and Influenza
Kanjo, K., Ghadiyaram, C., & Varadarajan, R. (2024) · Springer eBooks · doi:10.1007/978-981-97-0896-3_6
Costa, L. S. C., Guedes, I. A., Fanticelli, H. C., Nicolás, M., & Dardenne, L. E. (2024) · Computer-aided drug discovery and design · doi:10.1007/978-3-031-69162-1_8
Saenkham, P., Drelich, A. K., Huang, P., Peng, B., & Tseng, C.-T. K. (2024) · Journal of General Virology · doi:10.1099/jgv.0.002039 · Cited by 2
Viral Infections and Host Immunity: Lessons Learned from Model Organisms
Nainu, F., As’ad, M. F., & Mudjahid, M. (2024) · Integrated science · doi:10.1007/978-3-031-64292-0_17
Animal Models for Human-Pathogenic Coronavirus and Animal Coronavirus Research
Xiao, F., Hu, J., Xu, M., Wang, D., Shen, X., Zhang, H., Miao, J., Cai, H., Wang, J., Liu, Y., et al. (2025) · Viruses · doi:10.3390/v17010100
Wang, B.-H., Yu, K., Zhang, X., Sun, X.-H., Tang, L., & Shi, X.-L. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s480112
A rapid approach for linear epitope vaccine profiling reveals unexpected epitope tag immunogenicity
Browne-Cole, K., Hanning, K. R., Beijerling, K., Rousseau, M., Loh, J. M. S., & Kelton, W. (2025) · Scientific Reports · doi:10.1038/s41598-025-92928-3
Molecular mechanisms of RaTG13 and SARS ‐ CoV ‐2 RBD bound to Rhinolophus affinis bat ACE2
Wang, C., Li, M., Xu, N., Deng, Y., Fan, S., & Lan, J. (2025) · Protein Science · doi:10.1002/pro.70117
Self-citationWhy it matters that the coronavirus is changing – and what this means for vaccine effectiveness
Kennedy, D. A. (2020) · The Conversation · doi:10.64628/aai.ejnxnv3m9
Voici pourquoi les nouveaux variants de la Covid-19 se répandent dans le monde entier
Otto, S. P. (2021) · The Conversation · doi:10.64628/aap.3vjqd3crv
Molecular study of the SARS-CoV-2 new variants in Iran
Motazakker, M., & Bagheri, M. (2024) · Pneumologia · doi:10.2478/pneum-2025-0020
Olivera, N. A., García, M. C. C., Lesmes-Rodríguez, L. C., & Hernández, D. A. J. (2025) · Revista Sistemas de Producción Agroecológicos · doi:10.22579/22484817.1311
Soares, R. (2021) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/nxs4-xw58
Zhu, Y., Zhou, W., Niu, Z., Sun, J., Zhang, Z., Li, Q., Zheng, Y., Wang, C., Gao, L., & Sun, Q. (2022) · Figshare · doi:10.6084/m9.figshare.20004726
Additional file 3 of Genomic epidemiology of SARS-CoV-2 in Esteio, Rio Grande do Sul, Brazil
Franceschi, V. B., Caldana, G. D., de Menezes Mayer, A., Cybis, G. B., Neves, C. A. M., Ferrareze, P. A. G., Demoliner, M., de Almeida, P. R., Gularte, J. S., Hansen, A. W., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14633687
Cheng, L., Song, S., Zhou, B., Ge, X., Yu, J., Zhang, M., Ju, B., & Zhang, Z. (2021) · Figshare · doi:10.6084/m9.figshare.14509551
Qin, T., Shen, B., Li, E., Jin, S., Luo, R., Zhang, Y., Qi, J., Deng, X., Shi, Z., Wang, T., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22671338
Self-citationTillgren, S. M., Nieto-Fontarigo, J. J., Cerps, S., Ramu, S., Menzel, M., Persson, I. M., Meißner, A., Akbarshahi, H., & Uller, L. (2023) · Figshare · doi:10.6084/m9.figshare.22606982
SARS-COV-2 PATHOGENESIS AND THE HOST IMMUNE RESPONSE
Imbiakha, B. (2023) · eCommons (Cornell University) · doi:10.7298/fwwj-hr68
Additional file 2 of Genomic epidemiology of SARS-CoV-2 in Esteio, Rio Grande do Sul, Brazil
Franceschi, V. B., Caldana, G. D., de Menezes Mayer, A., Cybis, G. B., Neves, C. A. M., Ferrareze, P. A. G., Demoliner, M., de Almeida, P. R., Gularte, J. S., Hansen, A. W., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14633684
Tillgren, S. M., Nieto-Fontarigo, J. J., Cerps, S., Ramu, S., Menzel, M., Persson, I. M., Meißner, A., Akbarshahi, H., & Uller, L. (2023) · Figshare · doi:10.6084/m9.figshare.22606988
Yi, C., Sun, X., Lin, Y., Gu, C., Ding, L., Lu, X., Yang, Z., Zhang, Y., Ma, L., Gu, W., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16815699
Self-citationTillgren, S. M., Nieto-Fontarigo, J. J., Cerps, S., Ramu, S., Menzel, M., Persson, I. M., Meißner, A., Akbarshahi, H., & Uller, L. (2023) · Figshare · doi:10.6084/m9.figshare.22606994
Additional file 4 of Genomic epidemiology of SARS-CoV-2 in Esteio, Rio Grande do Sul, Brazil
Franceschi, V. B., Caldana, G. D., de Menezes Mayer, A., Cybis, G. B., Neves, C. A. M., Ferrareze, P. A. G., Demoliner, M., de Almeida, P. R., Gularte, J. S., Hansen, A. W., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14633690
Tillgren, S. M., Nieto-Fontarigo, J. J., Cerps, S., Ramu, S., Menzel, M., Persson, I. M., Meißner, A., Akbarshahi, H., & Uller, L. (2023) · Figshare · doi:10.6084/m9.figshare.22606991
Additional file 1 of Genomic epidemiology of SARS-CoV-2 in Esteio, Rio Grande do Sul, Brazil
Franceschi, V. B., Caldana, G. D., de Menezes Mayer, A., Cybis, G. B., Neves, C. A. M., Ferrareze, P. A. G., Demoliner, M., de Almeida, P. R., Gularte, J. S., Hansen, A. W., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14633681
Tillgren, S. M., Nieto-Fontarigo, J. J., Cerps, S., Ramu, S., Menzel, M., Persson, I. M., Meißner, A., Akbarshahi, H., & Uller, L. (2023) · Figshare · doi:10.6084/m9.figshare.22606985
Boudewijns, R. (2021) · Lirias (KU Leuven)
Studies of viral entry and viral proteases of coronaviruses and caliciviruses
Perera, K. D. (2022) · K-State Research Exchange (Kansas State University)
Phylogenetics for Genomic Epidemiology
van Dorp, L., & Balloux, F. (2025) · Springer eBooks · doi:10.1007/978-3-031-76448-6_3
Kurokawa, R., Mtali, C. S., Daniel, I. J., Einarsdottir, T., Reda, O., Irie, N., Sakhor, W., Niimura, K., Takatori, M., Sugata, K., et al. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1013866 · Cited by 1
IFITM3 deficiency drives SARS-CoV-2 adaptation while preserving variant-specific traits
Denz, P. J., Speaks, S., McFadden, M. I., Cable, J. M., Al-Adhami, A., Papa, J. L., Rayner, R. E., Rao, P. R., Leumi, S., Roettger, J. E., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68485-2
Structural basis for bat receptor recognition by SARS-CoV-2 and bat SARS2-like coronaviruses
Hsueh, F., Shi, K., Aihara, H., & Li, F. (2026) · Communications Biology · doi:10.1038/s42003-026-09682-z
Hakim, M. S., Widyaningsih, S. A., Ikram, A., Goeijenbier, M., Morita, A., & Yin, Y.-B. (2026) · Virology · doi:10.1016/j.virol.2026.110854
Budylowski, P. (2024) · TSpace (University of Toronto)
Clues to Long COVID Linked to Virulence and Infectivity Found in Shell Proteins
Goh, G. K., Foster, J. A., & Uversky, V. N. (2026) · Advances in respiratory medicine · doi:10.3390/arm94020018
Deep learning from phylogenies
Voznica, J. (2021) · theses.fr (ABES) · doi:10.70675/2a30342bz42dfz4c7az871cza4830f7c63f0
Analyse du cycle du SARS-CoV-2 en modèle cellulaire par microscopie électronique à transmission
Eymieux, S. (2023) · theses.fr (ABES) · doi:10.70675/b2613d6dz2a78z4ce7za880z900e0b790d14
Évaluation de théories sur l'origine du SARS-CoV-2 à la lumière de son évolution
Débarre, F., & Hensel, Z. (2026) · Comptes Rendus Biologies · doi:10.5802/crbiol.183-fr
Song, W., Chen, Y., Tong, Y., Liu, F., LI, C. W., Ye, Z., Ren, P., Wang, J., Cui, X., Lam, A. H.-C., et al. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-025-11418-z
Self-citationThe Mouse as a Cornerstone of Biomedical Research: A Biological Model for Human Health and Disease
Mori, P., Maniya, H., Chauhan, M., Goswami, S., & Kumar, V. (2026) · Springer eBooks · doi:10.1007/978-981-92-0038-2_6 · Cited by 1
Experimental evolution of Rc-o319 sarbecovirus spike protein reveals limited ACE2 adaptability
Moreno‐García, J., Dufloo, J., & Sanjuán, R. (2026) · Virus Evolution · doi:10.1093/ve/veag035
Broadly Protective Antibody‐Like Vaccines Against Highly Pathogenic Coronaviruses
Helal, A., Aljehani, N. D., Ghazwani, A. H., Alsulaiman, R. M., Alyami, F., Abdulaal, W. H., Alsharef, A., Alghanmi, M. S., Zawawi, A., Azhari, A., et al. (2026) · Journal of Medical Virology · doi:10.1002/jmv.71008
Development and characterization of mouse-adapted recombinant SARS-CoV-2 expressing reporter genes
Mahmoud, S. H., Jackson, N. D., Barre, R. S., Ma, Y., Bayoumi, M., Castro, E. M., Ezzatpour, S., Plemper, R. K., Perlman, S. M., Ye, C., et al. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.00444-26
Fan, Q., Pan, M., Jiang, M., Feng, C., Cui, J., Zhang, J., Liang, S., Wang, Y., Shi, J., Li, R., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-75678-2
Self-citation年齢依存的なSARS-CoV-2肺炎の重症度に関連する肺におけるウイルス特異的T細胞動態
Kurokawa, R. (2026) · Institutional Repositories DataBase (IRDB)
Lethal C57BL/6 mouse model for Yezo virus infection and antiviral therapeutic evaluation
Liu, Y., Liu, N., Zhang, G., Ziyan, L. I. U., Ji, T., Li, L., & Wang, Z. (2026) · Emerging Microbes & Infections · doi:10.1080/22221751.2026.2731505
Modeling the Exposome in Murine Cardiovascular Disease
Sulaman, B. A., Zhu, J., Xiong, T., Ireland, T. E., Downey, J., Świrski, F. K., Robbins, C. S., Leeper, N. J., Poller, W. C., & McAlpine, C. S. (2026) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2026.101690
Lipid raft protein Flotillin 2 facilitates alphavirus infection through promoting viral release
Guan, T., Zhang, Y., Wang, F., Lu, H., Wei, L., Zhao, W., & Cui, F. (2026) · Insect Science · doi:10.1111/1744-7917.70361
Thomas, S. V., Chen, J., Qian, D., Spearman, P. W., & Shi, D. (2026) · Bioengineering · doi:10.3390/bioengineering13101136
Characterization of SARS-CoV-2 Spike mutations
Schotsaert, M. (2025) · ImmPort · doi:10.21430/m301eut53a
Protective activity of mRNA vaccines
Krammer, F. (2024) · ImmPort · doi:10.21430/m3nt600qa9
Kraft, T. (2026) · University of Regensburg Publication Server (University of Regensburg) · doi:10.5283/epub.80837
Metadata
- Authors
- Gu, H., Chen, Q., Yang, G., He, L., Fan, H., Deng, Y.-Q., Wang, Y., Teng, Y., Zhao, Z., Cui, Y., Li, Y., Li, X.-F., Li, J., Zhang, N.-N., Yang, X., Chen, S., Guo, Y., Zhao, G., Wang, X., Luo, D.-Y., Wang, H., Yang, X., Li, Y., Han, G., He, Y., Zhou, X., Geng, S., Sheng, X., Jiang, S., Sun, S., Qin, C.-F., & Zhou, Y.
- Affiliations
- Academy of Military Medical Sciences (CN)
- Beijing Proteome Research Center (CN)
- State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China.
- Institute of Military Cognition and Brain Sciences, Beijing 100850, China.
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Beijing JOINN Biologics Co., Beijing 100176, China.
- Shanghai Medical College of Fudan University (CN)
- Corresponding author
- Gu, Hongjing
- Chen, Qi
- Yang, Guan
- He, Lei
- Fan, Hang
- Deng, Yong-Qiang
- Jiang, Shibo
- Sun, Shihui
- Qin, Cheng-Feng
- Zhou, Yusen
- ORCID
- Gu, Hongjing
- Chen, Qi
- Yang, Guan
- He, Lei
- Fan, Hang
- Deng, Yong-Qiang
- Wang, Yanxiao
- Teng, Yue
- Zhao, Zhongpeng
- Cui, Yujun
- Li, Yuchang
- Li, Xiao-Feng
- Li, Jiangfan
- Zhang, Na-Na
- Yang, Xiaolan
- Chen, Shaolong
- Guo, Yan
- Zhao, Guangyu
- Wang, Xiliang
- Wang, Hui
- Yang, Xiao
- Li, Yan
- Han, Gencheng
- He, Yuxian
- Zhou, Xiaojun
- Jiang, Shibo
- Sun, Shihui
- Qin, Cheng-Feng
- Zhou, Yusen
- Venue
- Science
- Published
- 2020-09-25
- Volume
- 369
- Issue
- 6511
- Pages
- 1603-1607
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC7574913
- OpenAlex
- W3045870925
- Cited by
- 762
- References
- 30
- Citations by year
- 2026: 20 · 2025: 36 · 2024: 66 · 2023: 82 · 2022: 194 · 2021: 321 · 2020: 42
- FWCI
- 21.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Science (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (82041006, 82041025)
- National Science Fund for Distinguished Young Scholars (81925025)
- National Science and Technology Major Project of China (2018ZX09711003, 2017ZX10304402)
- Beijing Municipal Science and Technology Project (201100001020004)
- National Key Plan for Scientific Research and Development of China (2016YFD0500304, 2016YFD0500306, 2020YFA0707801)
- Innovation Fund for Medical Sciences of the Chinese Academy of Medical Sciences. (2019-I2M-5-049)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS-CoV-2, BALB/c mice, vaccine efficacy, serial passage, N501Y mutation, spike protein receptor-binding domain, interstitial lung disease, aged mice, challenge model, adaptive mutation, viral virulence
- MeSH terms
- Immunogenicity, Vaccine, Betacoronavirus, Angiotensin-Converting Enzyme 2, COVID-19, SARS-CoV-2, COVID-19 Vaccines, Administration, Intranasal, Animals, Disease Models, Animal, Female, Humans, Peptidyl-Dipeptidase A, Lung, Mice, Inbred BALB C, Mice, Transgenic, Mutation, Pneumonia, Viral, Vaccines, Synthetic, Viral Vaccines, Virulence, Lung Diseases, Interstitial, Coronavirus Infections, Mice, Pandemics, High-Throughput Nucleotide Sequencing, Spike Glycoprotein, Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.